Diabetes Clinical Trials in Los Angeles

Showing 1-20 of 429 trials

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plus BI reigmen on participant and parent/legally authorized representative satisfaction. Participants will be followed for 13 weeks during the main phase followed by an optional Extension Phase for participants continuing to use Afrezza in combination with BI for up to 26 weeks.

Type 1 Diabetes Mellitus

Mannkind Corporation100 participantsStarted Feb 2026

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

Active Not RecruitingPhase 3< 1 mile

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

NCT06534411

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigational medicine. Doctors cannot yet prescribe CagriSema. CagriSema will be compared to a medicine called tirzepatide. Doctors can prescribe tirzepatide in some countries. Participants will either receive CagriSema or tirzepatide. Which treatment the participant will receive is decided by chance. For each participant, the study will last for up to 1 year and 4 months.

Diabetes Mellitus, Type 2

Novo Nordisk A/S1,023 participantsStarted Nov 2024

Pelham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +160 more locations

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Diabetes Trials in Other Cities

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Type 1 Diabetes Extension Study

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Other Conditions in Los Angeles